US Warrant News

Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial … – GlobeNewswire (press release)

Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial …GlobeNewswire (press release)… to common stockholders for the quarter and year ended December 31, 2014, compared with the same periods in 2013, resulted primarily from a reduction in non-cash accounting expense in 2014 related to the change in fair value of common stock warrants …Inovio […]

Inovio Pharmaceuticals Reports 2014 Fourth Quarter and Year End Financial … – GlobeNewswire (press release) Read More »

Minerva Neurosciences (NERV) Enters $31M Common, Warrants Private … – StreetInsider.com

Minerva Neurosciences (NERV) Enters $31M Common, Warrants Private …StreetInsider.comMinerva Neurosciences (NASDAQ: NERV) announced that it will raise approximately $31 million of gross proceeds in a private placement offering to several institutional investors, including 6,281,661 shares of common stock and warrants to purchase up to … and more …read more

Minerva Neurosciences (NERV) Enters $31M Common, Warrants Private … – StreetInsider.com Read More »

Galena Biopharma Announces Pricing of Public Offering of Common Stock and … – Nasdaq

Galena Biopharma Announces Pricing of Public Offering of Common Stock and …NasdaqEach unit consists of one share of common stock and a warrant to purchase 0.5 of a share of common stock at an exercise price of $2.08 per share. The warrants are immediately exercisable and expire on the fifth anniversary of the date of

Galena Biopharma Announces Pricing of Public Offering of Common Stock and … – Nasdaq Read More »

Galena Biopharma Announces Pricing of Public Offering of Common Stock and … – GlobeNewswire (press release)

Galena Biopharma Announces Pricing of Public Offering of Common Stock and …GlobeNewswire (press release)Each unit consists of one share of common stock and a warrant to purchase 0.5 of a share of common stock at an exercise price of $2.08 per share. The warrants are immediately exercisable and expire on the fifth anniversary of the

Galena Biopharma Announces Pricing of Public Offering of Common Stock and … – GlobeNewswire (press release) Read More »

Minerva Neurosciences Announces $31 Million Financing – GlobeNewswire (press release)

Minerva Neurosciences Announces $31 Million FinancingGlobeNewswire (press release)The purchase price for the common stock will be $4.81 per share. The purchase price for the warrants will be $0.125 per share of common stock subject to such warrants. The warrants will have an exercise price of $5.772 per share. The private placement … and more …read

Minerva Neurosciences Announces $31 Million Financing – GlobeNewswire (press release) Read More »

Minerva Neurosciences Announces $31 Million Financing – MarketWatch

Minerva Neurosciences Announces $31 Million FinancingMarketWatchMinerva Neurosciences, Inc. NERV, +0.21% today announced that it will raise approximately $31 million of gross proceeds in a private placement offering to several institutional investors, including 6,281,661 shares of common stock and warrants to … and more …read more

Minerva Neurosciences Announces $31 Million Financing – MarketWatch Read More »

Galena Biopharma Announces Proposed Public Offering of Common Stock and … – CNNMoney

Galena Biopharma Announces Proposed Public Offering of Common Stock and …CNNMoneyThe shares of common stock and warrants to purchase common stock are being offered as units. The shares of common stock and warrants are immediately separable and will be issued separately. Raymond James will act as sole book-running manager for … and more …read more

Galena Biopharma Announces Proposed Public Offering of Common Stock and … – CNNMoney Read More »

Galena Biopharma Announces Proposed Public Offering of Common Stock and … – MarketWatch

Galena Biopharma Announces Proposed Public Offering of Common Stock and …MarketWatchThe shares of common stock and warrants to purchase common stock are being offered as units. The shares of common stock and warrants are immediately separable and will be issued separately. Raymond James will act as sole book-running manager for … and more …read more

Galena Biopharma Announces Proposed Public Offering of Common Stock and … – MarketWatch Read More »

Scroll to Top